Home » Conferences & Events » Health Care » Reimbursement and Health Policy

Reimbursement and Health Policy

The 340B Drug Discount Program
February 12, 2013

Congress created the 340B program in 1992 to help uninsured indigent patients gain better...

The Reimbursement Landscape for Novel Diagnostics: Current Limitations.
January 6, 2011

Personalized medicine has the potential to revolutionize patient care. The fundamental goal in...

BioBytes: The Biotech Drug Delivery Timeline
June 23, 2010

Biotech research holds a great deal of promise for future innovation in the treatment of...

Healing, Fueling, Feeding: How Biotechnology Is Enriching Your Life.
May 1, 2010

Biotechnology is all around us and is already a big part of our lives, providing breakthrough...

More Articles →

Letters, Testimony & Comments

BIO’s comments on the Centers for Medicare and Medicaid Services’ (CMS) draft 2014 Call Letter
March 1 2013
  BIO’s comments on the Centers for Medicare and Medicaid Services’ (CMS) draft 2014 Call Letter, submitted Friday,...
Medicaid, Children’s Health Insurance Programs, and Exchanges
February 21 2013
Ms. Marilyn Tavenner, B.S.N., M.H.A. Acting Administrator Centers for Medicare & Medicaid Services Room 445–G, Hubert H....
CED: BIO's Comments in response to the Centers for Medicare and Medicaid Services’ (CMS) Draft Guidance for the Public, Industry, and CMS Staff Coverage with Evidence Development in the context of coverage decision
January 28 2013
Dear Dr. Jacques:            The Biotechnology Industry Organization (BIO) is pleased...
340B: BIO’s Comments to HRSA Regarding the Burden to Conduct 340B Audits
December 21 2012
The Biotechnology Industry Organization (“BIO”) is pleased to submit the following comments in response to “Proposed...
EHB: BIO’s Comments on the Essential Health Benefits Proposed Rule
December 21 2012
          The Biotechnology Industry Organization (BIO) is pleased to submit the following...
More Letters, Testimony & Comments →

Press Releases

BIO Applauds House Committee Vote to Repeal IPAB
March 6 2012
Washington, DC (March 6, 2012) – The Biotechnology Industry Organization (BIO) applauded the House Energy and...
BIO Announces Policy Panel Keynote Session for 2011 BIO International Convention
April 19 2011
WASHINGTON, D.C. (April 19, 2011) - Democratic and Republican party leaders and strategists will share their...
The Future of Healthcare Policy to be Plenary Discussion at 13th Annual BIO CEO & Investor Conference
February 9 2011
WASHINGTON, D.C. (Wednesday, February 09, 2011) -The Biotechnology Industry Organization (BIO) today announced that...
Challenges in Reimbursement Hamper Development of Novel Diagnostics
January 6 2011
WASHINGTON, D.C. (Thursday, January 06, 2011) - The Biotechnology Industry Organization (BIO) released today a report...
Media Registration for the 2011 BIO International Convention Now Available Online
January 3 2011
WASHINGTON, D.C. (Monday, January 03, 2011) - The Biotechnology Industry Organization (BIO) announced today that...
More Press Releases →